X4 Pharmaceuticals annual operating margin
2020
2024
2025
X4 Pharmaceuticals Operating Margin Growth & History (XFOR)
X4 Pharmaceuticals's operating margin was −247.44% for fiscal 2025.
View full X4 Pharmaceuticals company overviewX4 Pharmaceuticals annual operating margin history
| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −247.44% | +1176.14 pp |
| 2024 | 2024-12-31 | −1,423.58% | +572.22 pp |
| 2020 | 2020-12-31 | −1,995.80% | — |
X4 Pharmaceuticals quarterly operating margin
Q1.20
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q2 2026 | 2026-06-30 | −186.13% | +1143.41 pp |
| Q1 2026 | 2026-03-31 | −749.85% | −717.07 pp |
| Q4 2025 | 2025-12-31 | −922.86% | +1567.73 pp |
| Q3 2025 | 2025-09-30 | −1,558.58% | +4602.13 pp |
| Q2 2025 | 2025-06-30 | −1,329.55% | −13958.86 pp |
| Q1 2025 | 2025-03-31 | −32.78% | +319.92 pp |
| Q4 2024 | 2024-12-31 | −2,490.59% | — |
| Q3 2024 | 2024-09-30 | −6,160.71% | — |
| Q2 2024 | 2024-06-30 | 12,629.31% | — |
| Q1 2020 | 2020-03-31 | −352.70% | — |
X4 Pharmaceuticals operating margin trends
Across the available reported history, X4 Pharmaceuticals's operating margin increased from −1,423.58% to −247.44%, a change of +1176.14 percentage points. The latest reported quarter, Q2 2026, shows −186.13%.
About the metric
What operating margin means
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
Calculation and source
How operating margin is calculated
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review X4 Pharmaceuticals filings at SEC.gov ↗